Evidence map›Paper›PMID 35038785›Full record

ArticleAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons2022

High-density lipoprotein infusion protects from acute graft-versus-host disease in experimental allogeneic hematopoietic cell transplantation.

Cécile Chagué, Thomas Gautier, Ludivine Dal Zuffo, Jean-Paul Pais de Barros, Audrey Wetzel, Georges Tarris, Gaëtan Pallot, Laurent Martin, Séverine Valmary-Degano, Valérie Deckert and 3 more

Open access · greenAbstract read
In one paragraph

Article in American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Gut microbiota and acute graft-versus-host disease.Chinese journal of cancer research = Chung-kuo yen cheng yen chiu · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. High-density lipoprotein infusion protects from acute graft-versus-host disease in experimental allogeneic hematopoietic cell transplantation.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2022
    Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Cécile ChaguéUniversity Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098 RIGHT Interactions Greffon-Hôte-Tumeur/Ingénierie Cellulaire et Génique, LabEX LipSTIC, FHU INCREASE, Besançon, France.ORCID 0000-0002-7249-6047
Thomas GautierUniversity Bourgogne Franche-Comté, INSERM, LNC UMR1231, LabEX LipSTIC, Dijon, France.ORCID 0000-0003-1119-7382
Ludivine Dal ZuffoUniversity Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098 RIGHT Interactions Greffon-Hôte-Tumeur/Ingénierie Cellulaire et Génique, LabEX LipSTIC, FHU INCREASE, Besançon, France.
Jean-Paul Pais de BarrosUniversity Bourgogne Franche-Comté, INSERM, LNC UMR1231, LabEX LipSTIC, Dijon, France.ORCID 0000-0002-5124-2283
Audrey WetzelUniversity Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098 RIGHT Interactions Greffon-Hôte-Tumeur/Ingénierie Cellulaire et Génique, LabEX LipSTIC, FHU INCREASE, Besançon, France.
Georges TarrisUniversity Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098 RIGHT Interactions Greffon-Hôte-Tumeur/Ingénierie Cellulaire et Génique, LabEX LipSTIC, FHU INCREASE, Besançon, France.
Gaëtan PallotUniversity Bourgogne Franche-Comté, INSERM, LNC UMR1231, LabEX LipSTIC, Dijon, France.
Laurent MartinUniversity Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098 RIGHT Interactions Greffon-Hôte-Tumeur/Ingénierie Cellulaire et Génique, LabEX LipSTIC, FHU INCREASE, Besançon, France.
Séverine Valmary-DeganoService d'Anatomie et Cytologie Pathologiques, CHU Besançon, Besançon, France.
Valérie DeckertUniversity Bourgogne Franche-Comté, INSERM, LNC UMR1231, LabEX LipSTIC, Dijon, France.ORCID 0000-0001-5728-1710
Laurent LagrostUniversity Bourgogne Franche-Comté, INSERM, LNC UMR1231, LabEX LipSTIC, Dijon, France.ORCID 0000-0002-8878-6081
Etienne DaguindauUniversity Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098 RIGHT Interactions Greffon-Hôte-Tumeur/Ingénierie Cellulaire et Génique, LabEX LipSTIC, FHU INCREASE, Besançon, France.ORCID 0000-0001-7375-5656
Philippe SaasUniversity Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098 RIGHT Interactions Greffon-Hôte-Tumeur/Ingénierie Cellulaire et Génique, LabEX LipSTIC, FHU INCREASE, Besançon, France.ORCID 0000-0002-8857-9939
Inserm · FRCentre Hospitalier Universitaire de Besançon · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute graft-versus-host disease (aGVHD) is a major limitation of the therapeutic potential of allogeneic hematopoietic cell transplantation. Lipopolysaccharides (LPS) derived from intestinal gram-negative bacteria are well-known aGVHD triggers and amplifiers. Here, we explored the LPS metabolism in aGVHD mouse models using an innovative quantification method. We demonstrated that systemic LPS accumulation after transplantation was due, at least partly, to a defect in its clearance through lipoprotein-mediated transport to the liver (i.e., the so-called reverse LPS transport). After transplantation, reduced circulating HDL concentration impaired LPS neutralization and elimination through biliary flux. Accordingly, HDL-deficient (Apoa1

Indexed as

Graft vs Host DiseaseHematopoietic Stem Cell TransplantationAcute DiseaseAnimalsCD8-Positive T-LymphocytesLipopolysaccharidesLipoproteins, HDLMiceTransplantation, HomologousLipopolysaccharidesLipoproteins, HDLbone marrow/hematopoietic stem cell transplantationgraft-versus-host disease (GVHD)immune regulationliver disease: immune/inflammatorytranslational research/science

Identifiers

PMID35038785
PMCPMC9306461
OpenAlexW4205506280

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.